Position in VRTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$0
New position
Shares Held
0
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2026
1 quarter on record
Derivatives in VRTX
reported options exposure · as of Jun 30, 2026CallValue
$248,365
CallShares
500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Clear Street Group Inc. holds $1,757,761 across 29 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
16,968 | $1,188,269 | |
| 2 | ABVX |
Abivax S.A.
|
3,811 | $507,853 | |
| 3 | NTRB |
NutriBand Inc.
|
61,630 | $61,630 | |
| 4 | OABI |
OmniAb, Inc.
|
100 | $9 | |
| 5 | ESLA |
Estrella Immunopharma, Inc.
|
34,082 | $0 | |
| 6 | KTTAW |
Pasithea Therapeutics Corp.
|
380 | $0 | |
| 7 | SXTP |
60 Degrees Pharmaceuticals, Inc.
|
145,969 | $0 | |
| 8 | ICU |
SeaStar Medical Holding Corp
|
46,690 | $0 |
All Filings in VRTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $248,365 | 500 | Call | Sole | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||